SynthesisFrontiers in aging neuroscience2026
Effects of brain-computer interface-based rehabilitation on upper limb function, activities of daily living, and adverse events in patients with early stroke: a systematic review and meta-analysis.
Synthesis in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Brain-computer interface-based rehabilitation represents an emerging neurorehabilitation approach for post-stroke motor recovery, yet its comprehensive effects on patients in the early phase after stroke, typically defined as within 3 months of onset, remain to be fully established. This systematic review and meta-analysis evaluated effects of this intervention on upper limb function, activities of daily living, and adverse events in individuals with early stroke. Methods: This study was conducted following PRISMA guidelines. Eligibility criteria were established for randomized controlled trials that encompassed: (1) participants were adults (≥18 years) within 3 months of stroke onset with upper limb motor impairment; (2) interventions included brain-computer interface-based rehabilitation, and (3) outcomes that measured upper limb function, activities of daily living, and adverse events. A systematic search was performed across PubMed, Embase, Cumulative Index to Nursing and Allied Health Literature, Cochrane Library, and China National Knowledge Infrastructure databases from their inception to August 23, 2025. Two independent reviewers assessed eligibility, compiled data, and appraised methodological rigor, potential bias, and reliability of the evidence. Meta-analysis was performed using RevMan 5.4 (Cochrane Collaboration, UK) and Stata 18 (StataCorp., USA), applying random-effects models to calculate mean differences (MD) or risk ratios (RR) with 95% confidence intervals (CI). Subgroup analyses, meta-regression, sensitivity analyses, and publication bias assessments were conducted where appropriate. Results: Nine studies involving 642 participants (212 females and 430 males) with a mean age of 59.77 years were included. For primary outcomes, brain-computer interface-based rehabilitation significantly improved upper limb function in patients with early stroke (MD = 5.02, 95% CI: 3.20, 6.84). Subgroup analyses revealed that no statistically significant differences were observed in the improvement of upper limb functionality among various patient demographics and intervention characteristics (all Conclusions: Brain-computer interface-based rehabilitation is effective in improving upper limb motor function in patients with early stroke. Current evidence suggests a potential benefit for activities of daily living, but the evidence is of low certainty due to substantial heterogeneity and limited robustness. Subgroup analyses identified time from onset and intervention duration as potential effect modifiers for activities of daily living. Preliminary safety data from a single study are encouraging but insufficient to establish a safety profile. Further well-designed randomized controlled trials are needed to establish optimal brain-computer interface-based rehabilitation protocols, to confirm the potential benefit on activities of daily living with more robust evidence, and to evaluate long-term efficacy and safety. Systematic Review Registration: PROSPERO [Register number: CRD420251144151].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.